Kymera Therapeutics Presents New Clinical Data from Ongoing Phase 1 Trial of MDM2 Degrader KT-253 at ASCO Annual Meeting
June 01, 2024 08:00 ET
|
Kymera Therapeutics, Inc.
KT-253 demonstrates initial clinical proof of concept in patients with tumor types shown to be sensitive in preclinical models, including responses in MCC and AML Evidence of target engagement...
ENPH INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Enphase Energy, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
June 01, 2024 07:55 ET
|
Robbins Geller Rudman & Dowd LLP
SAN DIEGO, June 01, 2024 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that the Enphase class action lawsuit, captioned Bialic v. Enphase Energy, Inc., No....
Cullinan Therapeutics Announces Positive Initial Data from Pivotal Phase 2b REZILIENT1 Study of Zipalertinib
June 01, 2024 07:00 ET
|
Cullinan Therapeutics, Inc.
CAMBRIDGE, Mass., June 01, 2024 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM), a biopharmaceutical company focused on developing modality-agnostic targeted therapies, today...
Aduro Clean Technologies kündigt Privatplatzierung von bis zu 2,5 Mio. USD an
June 01, 2024 05:56 ET
|
Aduro Clean Technologies Inc.
NICHT ZUR VERTEILUNG AN NACHRICHTENAGENTUREN DER VEREINIGTEN STAATEN ODER ZUR VERBREITUNG IN DEN VEREINIGTEN STAATEN LONDON, Ontario, June 01, 2024 (GLOBE NEWSWIRE) -- Aduro Clean Technologies...
Aduro Clean Technologies annonce un placement privé d’un montant maximal de 2,5 millions de dollars
June 01, 2024 05:56 ET
|
Aduro Clean Technologies Inc.
NE PAS DISTRIBUER AUX AGENCES DE PRESSE DES ÉTATS-UNIS ET NE PAS DIFFUSER AUX ÉTATS-UNIS LONDON, Province de l’Ontario, 01 juin 2024 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc.. (« Aduro » ou...
VENTYX SHAREHOLDER REMINDER: BFA Law Reminds Ventyx Biosciences, Inc. (NASDAQ: VTYX) Shareholders to Contact the Firm About Ongoing Investigation
June 01, 2024 05:42 ET
|
Bleichmar Fonti & Auld
NEW YORK, June 01, 2024 (GLOBE NEWSWIRE) -- If you are a shareholder of Ventyx Biosciences (NASDAQ: VTYX), you are encouraged to obtain additional information by visiting...
SQSP (NYSE) REMINDER: BFA Law Reminds Squarespace Shareholders to Inquire About Ongoing Investigation into the $44 Buyout Offer
June 01, 2024 05:41 ET
|
Bleichmar Fonti & Auld
NEW YORK, June 01, 2024 (GLOBE NEWSWIRE) -- Leading law firm Bleichmar Fonti & Auld LLP is investigating the Squarespace (NYSE: SQSP) buyout from Permira. If you invested in Squarespace you are...
SPT (NYSE) FRAUD ALERT: Sprout Social, Inc. Investors who Lost Money when Stock Plummeted 40% are Encouraged to Contact BFA Law about Upcoming Deadline
June 01, 2024 05:39 ET
|
Bleichmar Fonti & Auld
NEW YORK, June 01, 2024 (GLOBE NEWSWIRE) -- Leading law firm Bleichmar Fonti & Auld LLP announces the upcoming July 12, 2024, deadline in the Sprout Social (Nasdaq: SPT) Securities Class Action...
PATH (NYSE) INVESTOR ALERT: UiPath, Inc. Investigated for Securities Fraud After 34% Stock Drop, Contact BFA Law if You Suffered Losses
June 01, 2024 05:37 ET
|
Bleichmar Fonti & Auld
NEW YORK, June 01, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into UiPath, Inc. (NYSE: PATH) for potential violations of the...
CERE (NASDAQ) REMINDER: BFA Law Reminds Cerevel Shareholders to Inquire About Ongoing Investigation into the $45 Merger Offer
June 01, 2024 05:36 ET
|
Bleichmar Fonti & Auld
NEW YORK, June 01, 2024 (GLOBE NEWSWIRE) -- Leading law firm Bleichmar Fonti & Auld LLP is investigating the merger between Cerevel Therapeutics Holdings, Inc. (Nasdaq: CERE) and AbbVie, Inc. If...